HSF1 and breast cancer: Because HSF1 overexpression is associated with poor prognosis and shorter life expectancy for breast cancer patients (Santagata et al, 2011; Mendillo et al, 2012; Gökmen-Polar & Badve, 2016), we hypothesized that it was involved in the molecular etiology leading to antiestrogen resistance.